Clinical Trials in Nashville

Showing 13701-13720 of 20,298 trials

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

NCT02319018

This phase I trial studies the side effects and best dose of alisertib when given together with combination chemotherapy in treating patients with gastrointestinal tumors. Alisertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as fluorouracil, leucovorin calcium, oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving alisertib with more than one drug (combination chemotherapy) may be a better treatment for gastrointestinal tumors.

Malignant Digestive System Neoplasm

National Cancer Institute (NCI)14 participantsStarted Aug 2015

New Haven, Connecticut, United States • New Haven, Connecticut, United States • Baltimore, Maryland, United States +2 more locations

COMPLETEDNA< 1 mile

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

NCT03120598

A cluster randomized experiment focused on testing the extent to which the organization-focused Implementation \& Sustainment Facilitation (ISF) strategy is an effective adjunct to the staff-focused Addiction Technology Transfer Center (ATTC) strategy.

Substance Use

RTI International190 participantsStarted Jan 2015

Phoenix, Arizona, United States • Claremont, California, United States • Irvine, California, United States +36 more locations

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

Find Trials by Condition in Nashville

SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma

Gastric Electrical Stimulation (GES) for the Treatment of Obesity

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

Medical Therapy of Prostatic Symptoms

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Multicenter Continuous Peripheral Nerve Block Surveillance Study

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation

Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer

A Study of Axitinib in Advanced Carcinoid Tumors

PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris